School of Graduate, Shanghai University of Traditional Chinese Medicine, 1200 Cai Lun Rd. Shanghai 201203, China; Shanghai Key Laboratory of Molecular Imaging, Shanghai University of Medicine and Health Sciences, 279 Zhouzhu Highway, Shanghai 201318, China; College of Medical Technology, Shanghai University of Medicine and Health Sciences, 279 Zhouzhu Highway, Shanghai 201318, China.
School of Graduate, Shanghai University of Traditional Chinese Medicine, 1200 Cai Lun Rd. Shanghai 201203, China; Shanghai Key Laboratory of Molecular Imaging, Shanghai University of Medicine and Health Sciences, 279 Zhouzhu Highway, Shanghai 201318, China.
Phytomedicine. 2024 Oct;133:155872. doi: 10.1016/j.phymed.2024.155872. Epub 2024 Jul 20.
Non-small cell lung cancer (NSCLC) accounts for 85 % of lung cancer, becoming the most mortality of all cancers globally. Blockage of autophagy in NSCLC represents a promising therapeutic strategy that inhibits angiogenesis and overcomes drug resistance. Natural ingredients in anti-tumor adjuvants are increasingly reported to promote cell death with less side effects and the potential to increase chemotherapeutic drugs sensitivity. Baicalin, a Scutellaria baicalensis-extracted flavonoid glycoside, is reported to induce death of NSCLC cells, however, its effects on autophagy in NSCLC cells remain unclear.
This study aimed to investigate the effect of baicalin on autophagic flux in NSCLC cells, unraveling the underlying mechanism including potential target and its role in cell death of NSCLC cells.
In vitro anti-cancer effects of baicalin were verified by evaluating proliferation, clone formation, cell cycle, and cell migration in three NSCLC cell lines (A549, H1299, and PC-9). In vivo anti-tumor efficacies of baicalin were evaluated in subcutaneous xenograft tumor model in nude mice. Autophagy characterization in NSCLC cells included autophagic marker detection by western blot and immunofluorescence staining, subcellular structure observation by TEM, lysosomal function by RNA-seq and fluorescence staining (LysoTracker®, LysoSensor®, and acridine orange). Based on RNA-seq and molecular biological verification using apoptotic, autophagic, and lysosomal inhibitors, potential target molecule of baicalin was verified via Ca flux assay, MCOLN3 knockdown by shRNA, and virtual molecular docking.
Baicalin inhibited NSCLC cell proliferation and migration, and suppressed tumor growth in vivo. Baicalin blocked the autophagic flux via activating the membranal cation channel MCOLN3 of lysosome, which disrupted its Ca balance and induced lysosome dysfunction, leading to failure of autolysosome degradation. The cytoplasmic Ca imbalance further resulted in depolarization of mitochondrial membrane potentials and ROS accumulation in NSCLC cells, mediating autophagy-related apoptosis.
This study demonstrated that baicalin inhibited autolysosome degradation by activating MCOLN3, leading to dysfunction in lysosomal pH elevation, thereby inhibiting autophagy in NSCLC, leading to apoptotic death of NSCLC cells. These findings enriched the existing theories of cancer therapy based on autophagy inhibition and underlying mechanisms of flavonoids as antitumor agents, paving the way for their clinical application in future.
非小细胞肺癌(NSCLC)占肺癌的 85%,是全球死亡率最高的癌症。在 NSCLC 中阻断自噬代表了一种有前途的治疗策略,它可以抑制血管生成并克服耐药性。抗肿瘤佐剂中的天然成分越来越多地被报道能促进细胞死亡,副作用更小,并有增加化疗药物敏感性的潜力。黄芩素是一种从黄芩中提取的黄酮类糖苷,据报道能诱导 NSCLC 细胞死亡,但它对 NSCLC 细胞自噬的影响尚不清楚。
本研究旨在探讨黄芩素对 NSCLC 细胞自噬流的影响,揭示其潜在的作用机制,包括潜在的靶点及其在 NSCLC 细胞死亡中的作用。
通过评估三种 NSCLC 细胞系(A549、H1299 和 PC-9)的增殖、克隆形成、细胞周期和细胞迁移,验证黄芩素的体外抗癌作用。在裸鼠皮下移植瘤模型中评价黄芩素的体内抗肿瘤疗效。通过 Western blot 和免疫荧光染色检测 NSCLC 细胞中的自噬标志物,透射电镜观察亚细胞结构,通过 RNA-seq 和荧光染色(LysoTracker®、LysoSensor®和吖啶橙)检测溶酶体功能,对 NSCLC 细胞中的自噬特征进行了描述。基于 RNA-seq 以及使用凋亡、自噬和溶酶体抑制剂的分子生物学验证,通过 Ca 流测定、MCOLN3 敲低 shRNA 和虚拟分子对接验证了黄芩素的潜在靶分子。
黄芩素抑制 NSCLC 细胞增殖和迁移,并抑制体内肿瘤生长。黄芩素通过激活溶酶体的膜阳离子通道 MCOLN3 阻断自噬流,破坏其 Ca 平衡并诱导溶酶体功能障碍,导致自噬体降解失败。细胞质 Ca 失衡进一步导致 NSCLC 细胞线粒体膜电位去极化和 ROS 积累,介导自噬相关凋亡。
本研究表明,黄芩素通过激活 MCOLN3 抑制自噬溶酶体降解,导致溶酶体 pH 升高功能障碍,从而抑制 NSCLC 中的自噬,导致 NSCLC 细胞凋亡性死亡。这些发现丰富了基于自噬抑制的现有癌症治疗理论和黄酮类作为抗肿瘤药物的潜在机制,为它们在未来的临床应用铺平了道路。